Mammo with Heart uses FDA-cleared AI technology to detect signs of breast arterial calcification (BAC) during routine mammograms — offering valuable insights into heart health without any extra scans or appointments.
Mammo with Heart is FSA & HSA eligible.
Frequently Asked Questions
What is Mammo with Heart?
Mammo with Heart is an FDA-cleared, artificial intelligence (AI) based software intended to detect the presence or absence of breast arterial calcifications (BAC), an incidental finding in both Full Field Digital Mammogram (FFDM) and Digital Breast Tomosynthesis (DBT) screening mammograms.
Why does breast arterial calcification matter?
Based on current research and published literature, Breast Arterial Calcifications (BAC) is currently considered to be a benign incidental finding without defined clinical importance to breast cancer screening. However, there is growing evidence that it is associated with other vascular calcifications and associated clinical outcomes. Patients identified with BAC may be candidates for additional clinical evaluation of general health.
Will someone talk to me about the results?
The radiologist will include the findings in your mammogram report, and your provider can explain what it means for you personally. If anything’s noted, it is a good idea to discuss it with your PCP.
How is it detected on my mammogram?
The cmAngio software reads your mammograms to determine the presence or absence and location of breast arterial calcification. An expert radiologist will review your results to confirm the findings.
Are there any exclusions to be aware of, or can anyone opt in?
Currently, patients with breast implants are excluded.
How often should I get this assessment?
We recommend you repeat the screening every year with your annual mammogram.
Mammo with Heart utilizes cmAngio®, an FDA-cleared artificial intelligence (AI) detection software, to determine the presence or absence of breast arterial calcification (BAC) as an incidental finding in standard-view screening mammograms. The cmAngio® software is not FDA-cleared for use with screening mammograms that require displacement or alternative views; therefore, Mammo with Heart is not available to patients who need alternative views for their screening. The detection of BAC indicates calcium buildup within the breast arterial wall. While BAC has been associated with an increased risk of coronary heart and cardiovascular disease, its presence or absence does not constitute a diagnosis and should not be used alone to determine cardiovascular risk. Results from Mammo with Heart may support further clinical evaluation or patient management at the discretion of a primary care physician, cardiologist, or other specialist. If BAC is detected, please consult your healthcare provider for additional information, assessment, or treatment options.